• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性膜性肾病即使肾小球免疫沉积物已被清除,肾病综合征仍可能复发或加重。

Relapse or worsening of nephrotic syndrome in idiopathic membranous nephropathy can occur even though the glomerular immune deposits have been eradicated.

机构信息

Departments of Internal Medicine and Pathology, The Ohio State University Medical Center, Columbus, Ohio 43210, USA.

出版信息

Nephron Clin Pract. 2011;119(2):c145-53. doi: 10.1159/000324762. Epub 2011 Jul 8.

DOI:10.1159/000324762
PMID:21757952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3214955/
Abstract

BACKGROUND

Relapse or worsening of nephrotic syndrome (NS) in idiopathic membranous nephropathy (IMN) is generally assumed to be due to recurrent disease. Here we document that often that may not be the case.

SUBJECTS AND METHODS

This is a prospective study of 7 consecutive IMN patients whose renal status improved, then worsened after completing a course of immunosuppressive therapy. Each underwent detailed testing and repeat kidney biopsy.

RESULTS

In 4 patients (group A), the biopsy showed recurrent IMN (fresh subepithelial deposits). Immunosuppressive therapy was begun. In the other 3 patients (group B), the biopsy showed that the deposits had been eradicated. However, the glomerular basement membrane (GBM) was thickened and vacuolated. Immunosuppressive therapy was withheld. Groups A and B were comparable except that group B had very high intakes of salt and protein, based on 24-hour urine testing. Reducing their high salt intake sharply lowered proteinuria to the subnephrotic range and serum creatinine stabilized.

CONCLUSION

This work is the first to demonstrate that relapse/worsening of NS can occur in IMN even though the GBM deposits have been eradicated. High salt and protein intake in combination with thickened and vacuolated GBM appears to be the mechanism.

摘要

背景

特发性膜性肾病(IMN)患者的肾病综合征(NS)复发或加重通常被认为是疾病复发所致。但在此我们证明事实并非总是如此。

对象与方法

这是一项连续纳入 7 例 IMN 患者的前瞻性研究,这些患者在完成一疗程免疫抑制治疗后,肾脏状况先改善后恶化。每位患者均接受了详细检查和重复肾活检。

结果

4 例患者(A 组)的活检显示为复发的 IMN(新鲜的上皮下沉积物),开始进行免疫抑制治疗。在另外 3 例患者(B 组)中,活检显示沉积物已被清除,但肾小球基底膜(GBM)增厚并出现空泡。未进行免疫抑制治疗。A 组和 B 组除了 B 组患者的 24 小时尿液检测提示高盐和高蛋白摄入量外,其他方面均相似。严格减少高盐和高蛋白的摄入量可使蛋白尿显著减少至亚肾病范围,且血清肌酐稳定。

结论

本研究首次证明,即使 GBM 沉积物已被清除,IMN 患者的 NS 仍可能复发或加重。高盐和高蛋白摄入结合增厚和空泡化的 GBM 似乎是其发病机制。

相似文献

1
Relapse or worsening of nephrotic syndrome in idiopathic membranous nephropathy can occur even though the glomerular immune deposits have been eradicated.特发性膜性肾病即使肾小球免疫沉积物已被清除,肾病综合征仍可能复发或加重。
Nephron Clin Pract. 2011;119(2):c145-53. doi: 10.1159/000324762. Epub 2011 Jul 8.
2
Factors affecting the long-term outcomes of idiopathic membranous nephropathy.影响特发性膜性肾病长期预后的因素。
BMC Nephrol. 2017 Mar 27;18(1):104. doi: 10.1186/s12882-017-0525-6.
3
The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.环孢素治疗肾病综合征的缓解并不能减缓特发性膜性肾病的进展。
Clin Nephrol. 2004 Jan;61(1):17-24. doi: 10.5414/cnp61017.
4
The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.他克莫司单药治疗特发性膜性肾病所致成人肾病综合征的疗效与安全性。
Ren Fail. 2017 Nov;39(1):512-518. doi: 10.1080/0886022X.2017.1325371.
5
Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.33例青少年特发性膜性肾病的临床病理特征
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Aug 20;39(4):544-551. doi: 10.3881/j.issn.1000-503X.2017.04.014.
6
Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome.儿童特发性膜性肾病:临床表现、治疗反应及长期预后
BMC Nephrol. 2007 Aug 6;8:11. doi: 10.1186/1471-2369-8-11.
7
Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.特发性膜性肾病患儿中抗M型磷脂酶A2受体抗体
Nephrology (Carlton). 2015 Aug;20(8):572-5. doi: 10.1111/nep.12478.
8
Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.膜性肾病伴慢性肾功能不全的肾病综合征自发缓解。
Nephrol Dial Transplant. 2012 Jan;27(1):231-4. doi: 10.1093/ndt/gfr285. Epub 2011 May 30.
9
Detection and clinical significance of glomerular M-type phospholipase A receptor in patients with idiopathic membranous nephropathy.特发性膜性肾病患者肾小球 M 型磷脂酶 A 受体的检测及临床意义。
Intern Med J. 2016 Nov;46(11):1318-1322. doi: 10.1111/imj.13233.
10
Clinical and pathological features of idiopathic membranous nephropathy in young people.年轻人特发性膜性肾病的临床和病理特征。
Nephrology (Carlton). 2019 Jun;24(6):599-604. doi: 10.1111/nep.13486. Epub 2019 Apr 29.

引用本文的文献

1
Is It Coincidence or Consequence for a Case with Antiphospholipid Antibody Syndrome Overlapping SLE to Develop an Immune Complex Nephropathy Followed by a Nonimmune Complex Podocytopathy?抗磷脂抗体综合征重叠系统性红斑狼疮的病例发生免疫复合物性肾病后又出现非免疫复合物性足细胞病,这是巧合还是必然结果?
Case Rep Nephrol. 2018 Jul 24;2018:6746473. doi: 10.1155/2018/6746473. eCollection 2018.
2
A system biology approach to understanding the molecular mechanisms of Gubentongluo decoction acting on IgA Nephropathy.一种基于系统生物学方法理解固本通络汤作用于IgA肾病分子机制的研究
BMC Complement Altern Med. 2016 Aug 24;16(1):312. doi: 10.1186/s12906-016-1268-9.
3
Differential diagnosis of glomerular disease: a systematic and inclusive approach.肾小球疾病的鉴别诊断:一种系统且全面的方法。
Am J Nephrol. 2013;38(3):253-66. doi: 10.1159/000354390. Epub 2013 Sep 13.

本文引用的文献

1
PLA2R autoantibodies and recurrent membranous nephropathy after transplantation.磷脂酶A2受体自身抗体与移植后复发性膜性肾病
N Engl J Med. 2010 Jul 29;363(5):496-8. doi: 10.1056/NEJMc1003066.
2
Idiopathic membranous nephropathy: getting better by itself.特发性膜性肾病:可自行好转。
J Am Soc Nephrol. 2010 Apr;21(4):551-2. doi: 10.1681/ASN.2010020185. Epub 2010 Mar 18.
3
Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy.特发性膜性肾病肾病综合征自发缓解。
J Am Soc Nephrol. 2010 Apr;21(4):697-704. doi: 10.1681/ASN.2009080861. Epub 2010 Jan 28.
4
Benefits of dietary sodium restriction in the management of chronic kidney disease.饮食中限制钠摄入在慢性肾脏病管理中的益处。
Curr Opin Nephrol Hypertens. 2009 Nov;18(6):531-8. doi: 10.1097/MNH.0b013e3283312fc8.
5
Random spot urine protein/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patients.随机尿蛋白/肌酐比值不能可靠估计系统性红斑狼疮肾炎患者的 24 小时尿蛋白量。
Nephron Clin Pract. 2009;113(3):c177-82. doi: 10.1159/000232599. Epub 2009 Aug 12.
6
Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.蛋白尿作为慢性肾脏病的替代结局:美国国家肾脏基金会和美国食品药品监督管理局主办的科学研讨会报告
Am J Kidney Dis. 2009 Aug;54(2):205-26. doi: 10.1053/j.ajkd.2009.04.029. Epub 2009 Jul 3.
7
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.M型磷脂酶A2受体作为特发性膜性肾病的靶抗原
N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.
8
Rituximab therapy for membranous nephropathy: a systematic review.利妥昔单抗治疗膜性肾病:一项系统评价
Clin J Am Soc Nephrol. 2009 Apr;4(4):734-44. doi: 10.2215/CJN.05231008. Epub 2009 Mar 11.
9
Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price?原发性肾小球肾炎中蛋白尿的缓解:我们知道目标,但我们知道代价吗?
Nat Clin Pract Nephrol. 2008 Oct;4(10):550-9. doi: 10.1038/ncpneph0915. Epub 2008 Aug 26.
10
Targeting proteinuria as a valid surrogate for individualized kidney protective therapy.将蛋白尿作为个体化肾脏保护治疗的有效替代指标。
Am J Kidney Dis. 2008 May;51(5):713-6. doi: 10.1053/j.ajkd.2008.03.013.